ProfileGDS5678 / 1444462_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 56% 59% 56% 57% 57% 55% 54% 57% 55% 57% 57% 57% 56% 57% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.4685556
GSM967853U87-EV human glioblastoma xenograft - Control 23.5456659
GSM967854U87-EV human glioblastoma xenograft - Control 33.4178156
GSM967855U87-EV human glioblastoma xenograft - Control 43.3968957
GSM967856U87-EV human glioblastoma xenograft - Control 53.4032957
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.4543455
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.4311354
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.4353657
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.3387955
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.4328457
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.4272257
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.4277557
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.4301856
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.4317257